Skip to main content
The BMJ logoLink to The BMJ
letter
. 1992 May 30;304(6839):1444. doi: 10.1136/bmj.304.6839.1444

Octreotide and urinary glycosaminoglycan in Graves' disease.

T C Chang, W C Yao, C C Chang
PMCID: PMC1882188  PMID: 1628036

Full text

PDF

Page 1444

1444

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chang T. C., Kao S. C., Huang K. M. Octreotide and Graves' ophthalmopathy and pretibial myxoedema. BMJ. 1992 Jan 18;304(6820):158–158. doi: 10.1136/bmj.304.6820.158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hansson H. A., Petruson B., Skottner A. Somatomedin C in pathogenesis of malignant exophthalmos of endocrine origin. Lancet. 1986 Jan 25;1(8474):218–219. doi: 10.1016/s0140-6736(86)90698-7. [DOI] [PubMed] [Google Scholar]
  3. Kahaly G., Schuler M., Sewell A. C., Bernhard G., Beyer J., Krause U. Urinary glycosaminoglycans in Graves' ophthalmopathy. Clin Endocrinol (Oxf) 1990 Jul;33(1):35–44. doi: 10.1111/j.1365-2265.1990.tb00463.x. [DOI] [PubMed] [Google Scholar]
  4. Malec P., Zeman K., Markiewicz K., Tchórzewski H., Nowak Z., Baj Z. Short-term somatostatin infusion affects T lymphocyte responsiveness in humans. Immunopharmacology. 1989 Jan-Feb;17(1):45–49. doi: 10.1016/0162-3109(89)90007-6. [DOI] [PubMed] [Google Scholar]
  5. Perros P., James R. A., Kendall-Taylor P. Octreotide and Graves' ophthalmopathy. BMJ. 1992 Feb 22;304(6825):507–507. doi: 10.1136/bmj.304.6825.507-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Tsao M., Ferrarini M., Evans C., Ambro A., Whiteside T. L. Purification of a glycosaminoglycan-stimulatory lymphokine from supernatants of in vitro-activated human mononuclear cells. Clin Immunol Immunopathol. 1989 Jan;50(1 Pt 1):122–131. doi: 10.1016/0090-1229(89)90227-4. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES